Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
  • Japan
Investment stages
  • Advisory
Industries
    About
    The MRL Ventures Fund (MRLV) is the corporate venture arm of Merck & Co., Inc., located in Cambridge, MA. The MRLV team, comprising experienced lifesciences venture Capital professionals, is dedicated to backing imaginative scientists and proven entrepreneurs globally. They focus on early stage, preclinical therapeutics companies across various therapeutic areas and modalities. MRLV does not invest in medical devices, diagnostic platforms, or Digitalhealth.
    Min check size
    $10K
    Max check size
    $1M
    Fund size
    NPS

    Investment Thesis

    The MRL Ventures Fund team invests globally in early stage, preclinical therapeutics companies to transform patient care.
    Lead investor
    Co Invest
    Number of exits
    Preferred contact method

    Portfolio

    Yurtle

    WNWN Foodlabs

    Maven

    Orbital Materials

    Uplink

    FINDS

    Ivy Protocol

    Agroleague

    Sojo

    Your Juno

    Connect Earth

    Superflows

    Thrift+

    Mindstone

    Clear

    Uphill

    Chatterbox

    Iconoclass

    GoParity

    KETS

    Nui Care

    Refive

    loc.tax

    Ohne

    tl;dv

    Vanilla Steel

    Outmind

    Knok

    Kitch

    Omocom

    Flecto

    Student Finance

    Fund number
    Vintage Year
    Net Internal Rate of Return
    Investment Multiple
    Capital Allocation
    Management Fee
    Carried Interest
    AUM
    Follow-on Investments
    Graduation Rate
    Write-Off Ratio
    Last profile update timestamp